STOCK TITAN

Editas Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Editas Medicine (Nasdaq: EDIT), a leader in genome editing, announced its participation in several upcoming investor conferences. The events include the 2022 Wells Fargo Healthcare Conference on September 7, with a 1:55 p.m. ET fireside chat in Everett, MA; the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, at 10:30 a.m. ET in New York, NY; and the Baird 2022 Global Healthcare Conference on September 13 in New York, NY. The chats will be webcast live and archived for 30 days on the company’s website.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following upcoming investor conferences:

  • 2022 Wells Fargo Healthcare Conference
    Format: Fireside Chat
    Date: Wednesday, September 7, 2022
    Time: 1:55 p.m. ET
    Location: Everett, MA
  • Morgan Stanley 20th Annual Global Healthcare Conference
    Format: Fireside Chat
    Date: Monday, September 12, 2022
    Time: 10:30 a.m. ET
    Location: New York, NY
  • Baird 2022 Global Healthcare Conference
    Date: Tuesday, September 13, 2022
    Location: New York, NY

The fireside chats will be webcast live and can be accessed through the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Harvard and Broad Institute’s Cas9 patent estates and Broad Institute’s Cas12a patent estate for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Media Contact:
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Investor Contact:
Ron Moldaver
(617) 401-9052
ir@editasmed.com


FAQ

When is Editas Medicine participating in the 2022 Wells Fargo Healthcare Conference?

Editas Medicine will participate in the 2022 Wells Fargo Healthcare Conference on September 7, 2022, at 1:55 p.m. ET.

What is the date and time of Editas Medicine's fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference?

The fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference will take place on September 12, 2022, at 10:30 a.m. ET.

Where is the Baird 2022 Global Healthcare Conference taking place?

The Baird 2022 Global Healthcare Conference will be held in New York, NY on September 13, 2022.

How can I access the webcasts of Editas Medicine's investor conferences?

The webcasts of Editas Medicine's investor conferences can be accessed through the 'Investors' section of their website.

Will the webcasts for Editas Medicine's conferences be available after the events?

Yes, an archived replay of the webcasts will be available for approximately 30 days following each event.

Editas Medicine, Inc.

NASDAQ:EDIT

EDIT Rankings

EDIT Latest News

EDIT Stock Data

110.61M
82.28M
0.32%
71.08%
19.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE